Depth of Response to Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone Improves Over Time in Patients With Transplant-Eligible Newly Diagnosed Multiple Myeloma: GRIFFIN Study Update
   Google Scholar   
Citation:
Bone Marrow Transplantation vol 55 p 127, abstr O120
Meeting Instance:
EBMT 2020
Year:
2020
Type:
Abstract
Sub type:
Oral
Funding:
AFT
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3304  
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
Janssen  
Grants:
 
Corr. Author:
 
Authors:
                                                         
Networks:
 
Study
AFT-29 (GRIFFIN)
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: